Lombard Odier Asset Management (Switzerland) Sa Moderna, Inc. Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$976 Million
Q2 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $273,490 - $397,192	2,016 New	2,016 $309,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $188,227 - $283,780	1,607 New	1,607 $230,000
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $228,766 - $425,205	-1,809 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $408,508 - $666,634	1,809 New	1,809 $459,000
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $480,191 - $1.05 Million	-2,164 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $16.3 Million - $29.5 Million	-125,540 Reduced 98.31%	2,164 $508,000
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $13.9 Million - $23.8 Million	127,704 New	127,704 $16.7 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account